Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.
Recalled November 13, 2019 · FDA recall D-0179-2020 · Dr. Reddy's Laboratories
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
N/A
Sold at
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →